Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study suggests that supplementing it in high doses could help reduce symptoms.

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the ...

In the United States, MDS cases are reported at a rate of 4.8 per 100,000 people annually, highlighting the pressing need for effective treatment solutions. As life expectancy increases globally, the ...

Researchers from institutions across France have uncovered solid clinical evidence that supplements of vitamin D could be an ...

Graves disease had similar presentation but a more severe clinical course when isolated than when part of autoimmune polyglandular syndrome.

Treatment with high-dose vitamin D reduced disease activity in people with clinically isolated syndrome in a Phase 3 trial.

Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...

Paris: A French study has revealed that taking vitamin D3 (cholecalciferol) orally at a dose of 100,000 international units ...